Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrobulbar Triamcinolone Acetonide Injection in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy

NCT02329288 is registered in ClinicalTrials.gov with Second Military Medical University as lead sponsor.

NCT NCT02329288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02329288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrobulbar Triamcinolone Acetonide Injection in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy
Lead sponsor
Second Military Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2015
Completion date
January 31, 2016
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

optic neuropathy, ischemic, triamcinolone acetonide